微信公众号

官网二维码

中国癌症防治杂志 ›› 2024, Vol. 16 ›› Issue (5): 540-548.doi: 10.3969/j.issn.1674-5671.2024.05.05

• CAR-T细胞治疗专栏 • 上一篇    下一篇

CAR-T细胞治疗相关不良反应防控及管理策略

  

  1. 北京高博博仁医院骨髓瘤淋巴瘤科
  • 出版日期:2024-10-25 发布日期:2024-11-06
  • 通讯作者: 张亚晶 E-mail:z18501333856@126.com
  • 基金资助:
    国家自然科学基金面上项目(3207080024)

Strategies for prevention,control and management of CAR-T cell therapy related adverse reactions

  • Online:2024-10-25 Published:2024-11-06

摘要: 合抗原受体T(chimeric antigen receptor T,CAR⁃T)细胞疗法作为一种新型的肿瘤免疫治疗方法,在治疗复发/难治性血液系统恶性肿瘤方面取得了显著成效。然而,CAR⁃T细胞治疗相关不良反应的发生在一定程度上影响了其临床获益。本文综述了CAR⁃T细胞治疗相关不良反应的分类及特点、风险因素、监测评估、预防措施及其管理的新进展,并总结CAR⁃T细胞治疗相关不良反应管理的现状与挑战,展望未来的研究方向,以期为临床医师提供该领域的新研究进展和应用指导,促进CAR⁃T细胞疗法的安全有效应用。

关键词: CAR-T细胞疗法, 不良反应, 细胞因子释放综合征, 神经系统毒性, 多学科管理

Abstract: Chimeric antigen receptor T (CAR⁃T) cell therapy, as a novel tumor immunotherapy, has achieved remarkable results in the treatment of relapsed/refractory hematological malignancies. However, the occurrence of CAR⁃T cell therapy⁃related adverse reactions has impacted its clinical benefits. This article reviews the classification and characteristics, risk factors, monitoring and assessment, preventive measures, and recent advancements in management of CAR⁃T cell therapy⁃related adverse reactions. It also summarizes the current status and challenges the management of CAR⁃T cell therapy⁃related adverse reactions and looks forward to future research directions, aiming to provide clinicians with the latest research progress and practical guidance in this field to promote the safe and effective application of CAR⁃T cell therapy.

Key words: CAR-T cell therapy, Adverse reactions, Cytokine release syndrome, Neurotoxicity, Multidisciplinary management

中图分类号: 

  • R730.5